Toxicology studies in patients on prolonged therapy with capreomycin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000995:Antitubercular Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004802:Eosinophilia / Q000209:etiology*; D005260:Female; D006309:Hearing; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007668:Kidney / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents